In the present study, an NMA was performed to evaluate the safety and efficacy of different molecular targeted therapies including VEGF(R), EGFR, HER2, mTOR and TKI in combination with chemotherapy for patient with GC. The gene discussed is EGFR; the disease is gastric cancer.